Preferred Label : Schwannomatosis, vestibular;
Symbol : SWNV;
CISMeF acronym : ACN; BANF; NF2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Bilateral acoustic neurofibromatosis; BANF; Acoustic neurinoma, bilateral; Neurofibromatosis, central type; ACN; Acoustic schwannomas, bilateral; Schwannomatosis 3; NF2; Neurofibromatosis, type II; SWN3;
Description : The central or type II form of neurofibromatosis (NF2) is an autosomal dominant multiple
neoplasia syndrome characterized by tumors of the eighth cranial nerve (usually bilateral),
meningiomas of the brain, and schwannomas of the dorsal roots of the spinal cord.
The incidence of neurofibromatosis type II is 1 in 25,000 live births (Asthagiri et
al., 2009). NF2 has few of the hallmarks of the peripheral or type I form of neurofibromatosis
(NF1; 162200), also known as von Recklinghausen disease. Asthagiri et al. (2009) provided
a detailed review of neurofibromatosis type II.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutations in merlin (NF2, 101000.0001);
Neoplasia : Meningioma; Neurofibroma; Vestibular Schwannoma (over 90% of patients); Astrocytoma; Ependymoma; Glioma;
Prefixed ID : #101000;
Origin ID : 101000;
UMLS CUI : C0027832;
Automatic exact mappings (from CISMeF team)
- Acnes [MedDRA High Level Term]
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)